Literature DB >> 7097493

Dissolution and bioavailability studies of whole and halved sustained-release theophylline tablets.

K J Simons, E M Frith, F E Simons.   

Abstract

In dissolution studies of whole and halved 100-mg sustained-release theophylline tablets, drug release from halved tablets was significantly higher. These differences were not reflected in the bioavailability studies. The area under the curve (AUC) mean absorption time and fraction-of-dose recovered in urine at 24 hr were not significantly different following the ingestion of whole or halved 100-mg tablets. The elimination rate constant, half-life, volume of distribution, plasma, and renal clearance values were consistent with values reported previously. Discrepancies were found in the 24-hr metabolite distribution as compared to literature values and may be accounted for by the age and health of the subjects and the frequency of dosing.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7097493     DOI: 10.1002/jps.2600710507

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  In vitro and in vivo evaluation of whole and half tablets of sustained-release adinazolam mesylate.

Authors:  J W Skoug; M T Borin; J C Fleishaker; A M Cooper
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

2.  Pharmacokinetic determinants in the design and evaluation of sustained-release dosage forms.

Authors:  H Boxenbaum
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

3.  Analysis of in vitro dissolution of whole vs. half controlled-release theophylline tablets.

Authors:  V P Shah; L A Yamamoto; D Schuirman; J Elkins; J P Skelly
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.